GILD

NASDAQ · Biotechnology

Gilead Sciences Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$126.13

-0.20 (-0.16%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 32 82%

Hold 7 18%

Sell 0 0%

Price Target

Analyst Price Target +187.5% upside

Low Target $213.16

Average Target $362.68

High Target $477.67

Current Price $126.13

Current
$126.13

Target
$362.68

$213.16 $362.68 avg $477.67

Scenario Analysis

Bear Case

$213.16

69.0%

Low target

Base Case

$362.68

+187.5%

Avg target

Bull Case

$477.67

+278.7%

High target

Risk/Reward

4.0x

Highly favorable

Price in Context

52-Week High

$157.29

-19.8% from high

52-Week Low

$104.46

+20.7% from low

50-Day SMA

$131.98

-4.4% vs SMA

200-Day SMA

$118.67

+6.3% vs SMA

RSI (14)

65.1

Neutral

Target vs 52W High

$362.68

+130.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%